From Discovery To Development To Delivery

AZBio is committed to building a top-tier life science industry in Arizona.

Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years.  (Get The Facts)

AZBio Members Are Making LIFE Bettter

AZBio Members discover, develop, and deliver life-saving and life-changing innovations.

Premiere Supporters

Leadership Supporters

Sustaining Members

Get Connected With Arizona's Bioindustry

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry.  AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.

Success Stories – Good News from Arizona’s BioIndustry

BD To Acquire Bard For $24 Billion

On on April 23, 2017, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical technology leader in the fields of vascular, urology, oncology and surgical specialty products, announced a definitive agreement under which BD will acquire Bard for $317.00 per Bard common […]

AZBio In The Loop for the Week of April 24, 2017

  The numbers from 2016 are in and AZBio Members who took advantage of AZBio Purchasing Power saved over $2.8 Million Dollars!  Any AZBio Member can take advantage of savings on a wide range of products and services.     Are YOU making the most of your opportunity to save with AZBio Purchasing Power? Click [...]

Events

AZBio Builds Relationships With Partners Across The Country

Partner Opportunities for AZBio Members

  • AZBio Members Save $100 Off Registration - Click here to learn more